Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F FROMM

Showing results (141-150 of 247) with videos related to

Pageof 25
Sort By:
Amino Acids|July 19, 2013
Transport of asymmetric dimethylarginine (ADMA) by cationic amino acid transporter 2 (CAT2), organic cation transporter 2 (OCT2) and multidrug and toxin extrusion protein 1 (MATE1)Joachim Strobel, Fabian Müller, Oliver Zolk, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 20, 2002
Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4Rajinder K Bhardwaj, Hartmut Glaeser, Laurent Becquemont, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|January 22, 2020
[Impact of Sedating Drugs on Falls Resulting Injuries Among People with Dementia in a Nursing Home Setting]Theresa Lippert, Renke Maas, Martin F Fromm, et al.
Pharmacogenetics and Genomics|July 19, 2006
Effect of SLCO1B1 polymorphism on induction of CYP3A4 by rifampicinMikko Niemi, Kari T Kivistö, Ulf Diczfalusy, et al.
Clinical Pharmacology and Therapeutics|March 6, 2004
Cytochrome P450 3A4 and P-glycoprotein expression in human small intestinal enterocytes and hepatocytes: a comparative analysis in paired tissue specimensOliver von Richter, Oliver Burk, Martin F Fromm, et al.
British Journal of Clinical Pharmacology|September 1, 1996
Expression of CYP3A4, CYP3A5 and CYP3A7 in human duodenal tissueK T Kivistö, G Bookjans, M F Fromm, et al.
Cellular Signalling|November 30, 2014
Interplay between the prostaglandin transporter OATP2A1 and prostaglandin E2-mediated cellular effectsKrystyna Bujok, Hartmut Glaeser, Wolfgang Schuh, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 3, 2018
Dose adjustment of cisplatin, etoposide, and ifosfamide according to kidney function: a retrospective analysis and implications for medication safetyCarolin Grafe, Sabine Semrau, Alexander Hein, et al.
Clinical Pharmacology and Therapeutics|September 17, 2004
Impact of concentration and rate of intraluminal drug delivery on absorption and gut wall metabolism of verapamil in humansHartmut Glaeser, Siegfried Drescher, Ute Hofmann, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 4, 2001
P-glycoprotein-mediated transport of digitoxin, alpha-methyldigoxin and beta-acetyldigoxinC Pauli-Magnus, T Mürdter, A Godel, et al.
Pageof 25

Showing results (141-150 of 247) with videos related to

Sort By:
Pageof 25
Amino Acids|July 19, 2013
Transport of asymmetric dimethylarginine (ADMA) by cationic amino acid transporter 2 (CAT2), organic cation transporter 2 (OCT2) and multidrug and toxin extrusion protein 1 (MATE1)Joachim Strobel, Fabian Müller, Oliver Zolk, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 20, 2002
Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4Rajinder K Bhardwaj, Hartmut Glaeser, Laurent Becquemont, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|January 22, 2020
[Impact of Sedating Drugs on Falls Resulting Injuries Among People with Dementia in a Nursing Home Setting]Theresa Lippert, Renke Maas, Martin F Fromm, et al.
Pharmacogenetics and Genomics|July 19, 2006
Effect of SLCO1B1 polymorphism on induction of CYP3A4 by rifampicinMikko Niemi, Kari T Kivistö, Ulf Diczfalusy, et al.
Clinical Pharmacology and Therapeutics|March 6, 2004
Cytochrome P450 3A4 and P-glycoprotein expression in human small intestinal enterocytes and hepatocytes: a comparative analysis in paired tissue specimensOliver von Richter, Oliver Burk, Martin F Fromm, et al.
British Journal of Clinical Pharmacology|September 1, 1996
Expression of CYP3A4, CYP3A5 and CYP3A7 in human duodenal tissueK T Kivistö, G Bookjans, M F Fromm, et al.
Cellular Signalling|November 30, 2014
Interplay between the prostaglandin transporter OATP2A1 and prostaglandin E2-mediated cellular effectsKrystyna Bujok, Hartmut Glaeser, Wolfgang Schuh, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 3, 2018
Dose adjustment of cisplatin, etoposide, and ifosfamide according to kidney function: a retrospective analysis and implications for medication safetyCarolin Grafe, Sabine Semrau, Alexander Hein, et al.
Clinical Pharmacology and Therapeutics|September 17, 2004
Impact of concentration and rate of intraluminal drug delivery on absorption and gut wall metabolism of verapamil in humansHartmut Glaeser, Siegfried Drescher, Ute Hofmann, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 4, 2001
P-glycoprotein-mediated transport of digitoxin, alpha-methyldigoxin and beta-acetyldigoxinC Pauli-Magnus, T Mürdter, A Godel, et al.
Pageof 25